BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29153094)

  • 41. The pathological features of leukemic cells infiltrating the renal interstitium in chronic lymphocytic leukemia/small lymphocytic lymphoma from a large single Chinese center.
    Wang H; Yu X; Zhang X; Wang S; Zhao M
    Diagn Pathol; 2021 Jul; 16(1):59. PubMed ID: 34218814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
    Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
    Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
    Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
    Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia.
    Ibrahem L; Elderiny WE; Elhelw L; Ismail M
    Blood Cells Mol Dis; 2015 Aug; 55(2):154-60. PubMed ID: 26142332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Teman CJ; Tripp SR; Perkins SL; Duncavage EJ
    Leuk Res; 2011 May; 35(5):689-92. PubMed ID: 21414663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.
    Sillé FC; Thomas R; Smith MT; Conde L; Skibola CF
    PLoS One; 2012; 7(1):e29632. PubMed ID: 22235315
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Boyer DF; Lindeman NI; Harris NL; Ferry JA
    Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
    Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
    Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages.
    Eksioğlu-Demiralp E; Alpdoğan O; Aktan M; Firatli T; Oztürk A; Budak T; Bayik M; Akoğlu T
    Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
    Dorfman DM; Pinkus GS
    Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies.
    Wang J; Coombes KR; Highsmith WE; Keating MJ; Abruzzo LV
    Bioinformatics; 2004 Nov; 20(17):3166-78. PubMed ID: 15231529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Mu Y; Fan X; Chen T; Meng Y; Lin J; Yuan J; Yu S; Chen Y; Liu L
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.
    Zucchetto A; Caldana C; Benedetti D; Tissino E; Rossi FM; Hutterer E; Pozzo F; Bomben R; Dal Bo M; D'Arena G; Zaja F; Pozzato G; Di Raimondo F; Hartmann TN; Rossi D; Gaidano G; Del Poeta G; Gattei V
    Blood; 2013 Nov; 122(19):3317-21. PubMed ID: 24068493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies.
    Kim C; Bassig BA; Seow WJ; Hu W; Purdue MP; Huang WY; Liu CS; Cheng WL; Männistö S; Vermeulen R; Weinstein SJ; Lim U; Hosgood HD; Bonner MR; Caporaso NE; Albanes D; Lan Q; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):148-53. PubMed ID: 25293880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.